An A1C test, also called a hemoglobin A1c or HbA1c test, measures average blood sugar levels over the prior 2 to 3 months and is the primary tool for diagnosing and monitoring diabetes and prediabetes. The Centers for Disease Control and Prevention estimates that 38 million Americans have diabetes and 98 million have prediabetes, making the A1C test one of the most commonly ordered lab tests in the country. The USPSTF issued a Grade B recommendation for prediabetes and Type 2 diabetes screening in adults 35 to 70 who have overweight or obesity, which means ACA-compliant plans must cover a qualifying screening A1C test at 100% with no cost-sharing for those patients.
The widest price gap in U.S. healthcare for the A1C test is not between providers, it is between sites of service. A retail walk-in lab charges $25 to $80 for the identical CPT 83036 blood test. A hospital outpatient lab billed under hospital outpatient department rules charges $150 to $500 for the same tube of blood, because a facility fee is layered on top. Patients who schedule an A1C test at a physician office connected to a hospital system may receive a bill with a hospital-outpatient facility component they did not expect. This guide explains how to navigate those pricing differences and how to protect yourself under the No Surprises Act and Good Faith Estimate rules that took effect January 1, 2022.
Medicare covers diabetes screening A1C tests at $0 for eligible at-risk beneficiaries (up to twice per year), and the 2026 Medicare Clinical Laboratory Fee Schedule sets the national payment rate for CPT 83036 at approximately $14, a fraction of what uninsured patients are billed at hospital outpatient labs. Uninsured adults who need an A1C test have multiple low-cost options, from direct-to-consumer lab services at $25 to $50, to federally qualified health centers that offer sliding-scale pricing down to $0 based on household income. The full cost breakdown, Medicare rules, and Good Faith Estimate process are covered in detail below.
A1C Test Cost by Site of Service in 2026
The biggest cost driver of A1C Test is the site of service: where the procedure is performed. 2026 CMS price transparency data confirms a 2-3x billing differential between independent centers and hospital outpatient departments.
A1C Test prices without insurance vs. 2026 Medicare rates| Site of Service | Range Without Insurance | 2026 Medicare Rate |
|---|
| Independent retail lab (Quest, Labcorp, walk-in lab) | $25 to $80 | $14 (CLFS rate) |
| Physician office or urgent care center | $50 to $150 | $14 (CLFS rate) |
| Hospital outpatient lab | $150 to $500 | $14 (CLFS rate; facility fee billed separately) |
| Direct-to-consumer online lab order (Personalabs, Ulta Lab Tests) | $8 to $50 | Not applicable (Medicare does not cover self-ordered tests) |
2026 ranges reflect Medicare Clinical Laboratory Fee Schedule rate for CPT 83036, FAIR Health Consumer benchmarks, and CMS hospital price transparency data. Without-insurance (cash) prices vary by region and billing model. Independent lab and direct-to-consumer prices are the lowest-cost option for most uninsured patients.
Source: CMS 2026 Clinical Laboratory Fee Schedule, FAIR Health Consumer 2026, CMS Hospital Price Transparency
Why the Same Procedure Is So Much More at a Hospital
The biggest 2026 cost driver for an A1C test is not the test itself but whether the lab bills as an independent clinical lab or as a hospital outpatient department. An independent lab (Quest Diagnostics, Labcorp, or a local reference lab) files a simple claim under the Medicare Clinical Laboratory Fee Schedule for roughly $14. A hospital-affiliated lab that is designated as a hospital outpatient department under CMS rules adds a facility fee on top of the lab component, pushing the chargemaster billed charge to $150 to $500 for the exact same CPT 83036 blood test. The lab work is identical. The billing classification is not.
Patients who use a physician office that has been converted to a provider-based billing model under a hospital system may find their A1C test billed as hospital outpatient even though the blood was drawn in a clinic that looks nothing like a hospital. CMS price transparency rules now require hospitals to post lab prices in machine-readable format, but patients rarely check before scheduling a routine blood test. The practical fix: call the lab or the clinic before scheduling and ask directly whether the billing is under an independent lab or a hospital outpatient department. A one-minute phone call can save $100 to $400.
A1C Test Cost by Purpose and Setting in 2026
The A1C test is used for different clinical purposes, and the billing context changes the patient's out-of-pocket cost significantly. A screening A1C for a qualifying patient on an ACA-compliant plan costs $0. A monitoring A1C for a diagnosed diabetic patient counts toward the deductible and coinsurance. At-home A1C kits (CPT 83037) give a rough result but are not accepted for Medicare or insurance billing. The table below maps the most common billing scenarios to expected 2026 patient costs.
Typical cost by variant| Use case | Who it applies to | Patient cost (ACA-compliant plan) | Patient cost (Medicare) |
|---|
| Diabetes screening (USPSTF Grade B) | Adults 35 to 70 with overweight or obesity; no prior diagnosis | $0 (preventive, no cost-sharing) | $0 (up to 2 per year; provider accepts assignment) |
| Diabetes monitoring (diagnosed patient) | Patient already diagnosed with diabetes; test for ongoing management | Deductible + coinsurance apply | 20% coinsurance after $283 Part B deductible (2026) |
| Prediabetes management follow-up | Patient with confirmed prediabetes being monitored | Often $0 on ACA plan if ordered as preventive | $0 if qualifying screening; otherwise 20% coinsurance |
| At-home A1C kit (FDA-cleared device) | Self-monitoring, not for insurance or Medicare billing | Not billable to insurance; retail $25 to $50 per kit | Not covered (Medicare does not cover self-ordered home tests) |
ACA plans must cover USPSTF Grade B preventive services at 100% with no deductible or copay when an in-network provider performs the test. If the A1C is ordered for diagnosis or monitoring rather than screening, cost-sharing applies. Always confirm with your plan how the test is being billed. Medicare covers up to 2 qualifying diabetes screening tests per year at $0 per the medicare.gov diabetes screenings coverage page.
Source: CMS 2026 Clinical Laboratory Fee Schedule, USPSTF Recommendation Statement 2021, HealthCare.gov ACA Preventive Services Guidance
What Medicare Pays for A1C Test
Original Medicare Part B covers diabetes screening A1C tests at $0, with no 2026 Part B deductible of $283 and no coinsurance, for beneficiaries who are at risk for developing diabetes. Coverage applies to up to 2 screenings per calendar year. Qualifying risk factors under Medicare include age 65 or older with overweight, family history of diabetes, gestational diabetes history, or prior diagnosis of prediabetes. The Medicare Clinical Laboratory Fee Schedule (CLFS) sets the 2026 payment rate for CPT 83036 (Hemoglobin A1c, glycosylated) at approximately $14. That is the total amount Medicare pays the lab. The patient pays $0 for a qualifying screening. For a diagnostic or monitoring A1C ordered for a patient already diagnosed with diabetes, Original Medicare applies 20% coinsurance after the $283 Part B deductible.
Medicare Advantage plans must cover the same diabetes screening benefit as Original Medicare (up to 2 A1C screenings per year at $0 for qualifying patients), but plans may differ in how they handle diagnostic or monitoring A1C tests. Some Medicare Advantage plans include additional diabetes-related benefits beyond what Original Medicare covers, such as enhanced diabetes management programs or lower copays for monitoring lab work. Medigap supplemental insurance covers the 20% coinsurance that Original Medicare leaves to the beneficiary on diagnostic and monitoring A1C tests, so beneficiaries with both Original Medicare and Medigap typically pay $0 for covered lab tests. Commercial ACA-compliant plans must cover a USPSTF Grade B screening A1C test at $0 for adults 35 to 70 who have overweight or obesity when an in-network provider orders the test as a preventive service.
Under the No Surprises Act, effective January 1, 2022, every patient who pays cash or is uninsured has the right to a written Good Faith Estimate from the provider or lab before a scheduled A1C test. For an A1C test scheduled at least 10 business days in advance, the lab must furnish the Good Faith Estimate at least 3 business days before the service date. For an appointment scheduled 3 to 9 business days out, the GFE arrives at least 1 business day before service. Walk-in and same-day lab visits do not trigger the advance-notice requirement, but the patient can still request a written price estimate before the blood draw. The federal No Surprises Act consumer portal is at cms.gov/nosurprisesact.
To request a Good Faith Estimate for an A1C test in 2026, follow these steps: (1) Call the lab or physician office before scheduling and identify yourself as self-pay or uninsured. (2) Ask for a written Good Faith Estimate that includes the CPT code (83036 for a standard A1C), any separate phlebotomy or draw fee, the facility fee if the lab is hospital-affiliated, and all expected charges. (3) Provide your ZIP code and confirm whether the order includes any additional tests so the estimate is complete. (4) Confirm the timing: if your appointment is 10 or more business days out, the GFE must arrive at least 3 business days before your test; if 3 to 9 business days out, at least 1 business day before. (5) Keep the written Good Faith Estimate. If the final bill exceeds the GFE by $400 or more, you have the right to file a patient-provider dispute resolution claim within 120 days of the bill date through the federal portal at cms.gov/nosurprisesact.
A Good Faith Estimate for an A1C test is not a guaranteed final bill. Common reasons the actual charges exceed the estimate include: additional lab tests ordered during the same visit, a phlebotomy draw fee billed separately from the lab test, a hospital facility fee added when the blood is drawn at a provider-based clinic rather than an independent lab, and supplies or handling fees not itemized in the original estimate. For most stand-alone A1C tests at independent labs, the test is straightforward and the final bill rarely diverges from the estimate. The risk is highest when the blood draw happens inside a hospital-connected facility.
What Factors Affect Cost
- Site of service: an independent retail lab (Quest, Labcorp) charges $25 to $80; a hospital outpatient lab charges $150 to $500 for the identical CPT 83036 test. Always confirm the billing classification before you schedule.
- Billing purpose (screening vs diagnostic vs monitoring): a USPSTF-qualifying screening A1C is $0 on ACA-compliant plans and Medicare for eligible patients. A monitoring or diagnostic A1C for a diagnosed diabetic patient triggers deductible and coinsurance on both ACA plans and Original Medicare.
- Independent retail lab cash bundles: walk-in lab services such as Personalabs, Ulta Lab Tests, and Walk-In Lab publish flat cash prices of $8 to $50 for an A1C test, typically 60 to 80 percent below hospital outpatient chargemaster rates. No physician order is required in most states.
- Hospital chargemaster discount ask: if you must use a hospital-affiliated lab, ask explicitly for the self-pay or uninsured discount rate. Most hospitals publish a self-pay discount policy of 20 to 60 percent off the chargemaster price, and some apply the discount automatically when you identify as uninsured. Ask the billing department in writing for the hospital's published self-pay rate before the test.
- Sliding-scale Federally Qualified Health Centers (FQHCs): for patients whose household income falls at or below 100 percent of the federal poverty level ($15,650 for a household of 1 in 2026), FQHCs offer sliding-scale fees that can bring an A1C test to $0 or near-zero. The HRSA FQHC locator at findahealthcenter.hrsa.gov lists FQHCs by ZIP code.
- Phlebotomy draw fee: some labs charge a separate venipuncture or blood draw fee of $5 to $20 on top of the A1C test fee. When requesting a Good Faith Estimate, ask whether the draw fee is included in the quoted price or billed separately.
- Prior authorization: most commercial and Medicare Advantage plans do not require prior authorization for a routine A1C test. However, if the plan categorizes frequent monitoring tests (more than 4 per year) as non-routine, prior authorization may be required. Check your plan's evidence of coverage or call member services before ordering multiple A1C tests in a single plan year.
Common A1C Test Billing Errors
A1C tests generate billing errors most often when the clinical context is ambiguous (screening vs monitoring) or when the billing site differs from what the patient expected. Check for these errors before paying any A1C bill:
- Screening A1C billed as diagnostic or monitoring, triggering deductible and coinsurance when the patient qualifies for $0 coverage under ACA preventive care. Confirm the billing code with your insurer if you receive an unexpected bill.
- Hospital outpatient facility fee added when blood was drawn at a physician office or clinic connected to a hospital system. The lab component is $14 under the 2026 Medicare CLFS; the hospital facility charge on the same visit can be $100 to $300 extra.
- Duplicate billing: both a lab component and a physician-interpretation fee for a routine A1C test. Standard A1C tests do not require separate physician interpretation billing. Flag any charge labeled 'interpretation' or 'physician review' for a simple CPT 83036 test.
- Phlebotomy draw fee not disclosed in the upfront quote. Ask for an itemized Good Faith Estimate that shows the lab fee and the draw fee as separate line items before scheduling.
- Medicare Advantage plan billing the patient for a diabetes screening A1C when the patient qualifies for $0 cost-sharing. Medicare Advantage must match Original Medicare's zero-cost-sharing diabetes screening benefit for qualifying patients.
Frequently Asked Questions
How much does an A1C test cost without insurance in 2026?
Without insurance in 2026, an A1C test costs $25 to $80 at an independent retail or walk-in lab (Quest Diagnostics, Labcorp, Personalabs), $50 to $150 at a physician office or urgent care center, and $150 to $500 at a hospital outpatient lab. The national median across all sites is approximately $45. The site of service is the biggest cost driver: hospital-affiliated labs add a facility fee that can push the same CPT 83036 blood test to 3 to 5 times the independent lab price. Direct-to-consumer online lab services offer the lowest cash prices, often $8 to $50 with no doctor visit required.
What does Medicare pay for an A1C test in 2026?
Original Medicare Part B covers qualifying diabetes screening A1C tests at $0 for at-risk beneficiaries, with no 2026 Part B deductible and no coinsurance. Medicare covers up to 2 diabetes screenings per calendar year. The 2026 Medicare Clinical Laboratory Fee Schedule rate for CPT 83036 is approximately $14. For a diagnostic or monitoring A1C ordered for a patient already diagnosed with diabetes, Original Medicare applies 20% coinsurance after the $283 Part B deductible. Medicare Advantage plans must match the same $0 diabetes screening benefit. Medigap supplements the 20% coinsurance on non-screening A1C tests covered under Part B.
How do I request a Good Faith Estimate for an A1C test?
Under the No Surprises Act, any self-pay or uninsured patient can request a written Good Faith Estimate before scheduling an A1C test. Call the lab or physician office and identify yourself as self-pay. Ask for a written estimate that lists the CPT code (83036), any phlebotomy draw fee, and any hospital facility fee if the lab is hospital-affiliated. If your appointment is 10 or more business days out, the provider must deliver the GFE at least 3 business days before service. If scheduled 3 to 9 business days out, the GFE must arrive 1 business day before service. Keep the GFE: if your final bill exceeds the estimate by $400 or more, you can file a patient-provider dispute resolution claim within 120 days at cms.gov/nosurprisesact.
What is the No Surprises Act and does it apply to A1C testing?
The No Surprises Act took effect January 1, 2022, and gives uninsured and self-pay patients the right to a written Good Faith Estimate before any scheduled medical service, including lab tests like the A1C. The law covers providers and facilities across the board: hospitals, physician offices, independent labs, urgent care centers. If your final bill exceeds the GFE by $400 or more, you can dispute it through the federal patient-provider dispute resolution process at cms.gov/nosurprisesact within 120 days of the bill date. The No Surprises Act does not cover Medicare or Medicaid patients, who have their own cost protections.
How do I get a written cash-pay quote for an A1C test?
The fastest way to get a cash-pay price for an A1C test in 2026 is to use a direct-to-consumer lab ordering service such as Personalabs, Ulta Lab Tests, or Walk-In Lab, where prices are published online at $8 to $50. For Quest Diagnostics or Labcorp, call or visit the patient service center website and ask for the self-pay price before your appointment. For physician offices, call the billing department and ask specifically for the self-pay or uninsured cash rate. Avoid scheduling at a hospital-affiliated outpatient lab without first confirming whether a hospital facility fee will be added to your bill. Always request the quote in writing as a Good Faith Estimate so you have dispute rights if the final bill is higher.
Can I negotiate an A1C test bill after the fact?
Yes. Even after you receive an A1C bill, you can negotiate. For hospital-billed A1C tests, call the billing department and ask for the hospital's published self-pay or financial assistance rate; most hospitals offer 20 to 60 percent reductions off the chargemaster price for cash-pay patients. If your bill is higher than a Good Faith Estimate you received, you have the right to a patient-provider dispute resolution process at cms.gov/nosurprisesact within 120 days of the bill date when the overage is $400 or more. For a routine lab test, asking for a billing review and pointing to comparable independent-lab prices often results in a meaningful reduction.
What is the difference between hospital and independent lab A1C test costs?
An independent lab (Quest Diagnostics, Labcorp, or a local clinical lab) files a single CLFS claim for the CPT 83036 test at roughly $14 to $80 cash. A hospital outpatient lab for the same test adds a hospital facility fee, pushing the chargemaster-billed amount to $150 to $500. Both labs run the same test with the same analytical method and report the same result. The difference is entirely in the billing model: provider-based billing at hospital-affiliated clinics generates a two-part bill (facility fee plus lab fee) while independent labs generate a single-line lab bill. CMS price transparency data confirms this 3-to-5x spread for routine blood tests at hospital vs independent labs.
Is an A1C test covered by ACA preventive care?
Yes, for qualifying patients. The USPSTF issued a Grade B recommendation for prediabetes and Type 2 diabetes screening in adults 35 to 70 years old who have overweight or obesity. Under the ACA, Grade B preventive services must be covered at 100% with no deductible, no copay, and no coinsurance by ACA-compliant plans when an in-network provider performs the test as a preventive service. If the A1C is ordered for diagnosis or monitoring of an existing condition rather than screening, standard cost-sharing applies. Confirm with your insurance how the test is coded before scheduling to avoid an unexpected bill.
What is the difference between an A1C test and a fasting glucose test for diabetes screening?
An A1C test measures the percentage of glycated hemoglobin in the blood, reflecting average blood sugar over the past 2 to 3 months. No fasting is required. A fasting glucose test measures blood sugar after an 8-hour fast and reflects a single-point-in-time reading. Both tests are accepted by USPSTF and Medicare for diabetes screening. The A1C is more convenient because it requires no fasting, but it can be less accurate in patients with certain hemoglobin variants. Cost-wise, both tests are covered at $0 by Medicare for qualifying screening indications and by ACA plans under the USPSTF Grade B recommendation. The cash price for a fasting glucose test is typically $10 to $40 at independent labs, compared to $25 to $80 for an A1C.
Can I get an A1C test without a doctor's order in 2026?
Yes, in most states. Direct-to-consumer lab services such as Personalabs, Ulta Lab Tests, Walk-In Lab, and Quest Direct allow patients to order an A1C test online without a physician referral and visit a local patient service center for the blood draw. Prices for no-order A1C tests run $8 to $50 in 2026. Note that results from direct-to-consumer tests are not automatically forwarded to your physician and will not satisfy insurance or Medicare billing; they are for personal awareness only. If you receive an abnormal result, follow up with a clinician for a clinically ordered test that can support a formal diagnosis.
